US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
Abattis Bioceuticals Corp (ATT) 銘柄情報

Abattis Bioceuticals Corp (ATT)

0.08

0.00

(0.00%)

終了 6月5日 5:00AM

Abattis Bioceuticals Corp (ATT) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.08

( - )

買値

0.04

売値

10.00

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.08

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 49,944

発行済株式数

476,054,139

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.01

歳入

356.88k

純利益

-3.04M

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid... Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.abattis.com

本社

Vancouver, Canada

設立

1997

Abattis Bioceuticals Corp is listed in the sector of the Canadian Securities Exchange with ticker ATT. The last closing price for Abattis Bioceuticals was $0.08. Over the last year, Abattis Bioceuticals shares have traded in a share price range of $ 0.00 to $ 0.00.

Abattis Bioceuticals currently has 476,054,139 shares in issue. The market capitalisation of Abattis Bioceuticals is $38.08 million. Abattis Bioceuticals has a price to earnings ratio (PE ratio) of -0.00.

Abattis Provides Update on Trading Halt and Corporate Developments

VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or...

Abattis Completes Year End Audit and Provides Corporate Update

VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ATT - Frequently Asked Questions (FAQ)

What is the current Abattis Bioceuticals Corp share price?

The current share price of Abattis Bioceuticals Corp is $ 0.08

How many Abattis Bioceuticals Corp shares are in issue?

Abattis Bioceuticals Corp has 476,054,139 shares in issue

What is the market cap of Abattis Bioceuticals Corp?

The market capitalisation of Abattis Bioceuticals Corp is CAD 38.08M

What is the 1 year trading range for Abattis Bioceuticals Corp share price?

Abattis Bioceuticals Corp has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Abattis Bioceuticals Corp?

The price to earnings ratio of Abattis Bioceuticals Corp is -0

What is the cash to sales ratio of Abattis Bioceuticals Corp?

The cash to sales ratio of Abattis Bioceuticals Corp is 0

What is the registered address of Abattis Bioceuticals Corp?

The registered address for Abattis Bioceuticals Corp is 625 Howe Street, Vancouver, British Columbia, V6C 2M6

What is the Abattis Bioceuticals Corp website address?

The website address for Abattis Bioceuticals Corp is www.abattis.com

Pickthepenny

Pickthepenny 7年前

This is a good possibility here. Looks like this may be something good to dip into

Alaska33

Alaska33 8年前

HIPH
Check it out...another runner this week!

KOLBYDOG

KOLBYDOG 8年前

ATT I'll take .215. Great late run, hopefully continues Tuesday.

KOLBYDOG

KOLBYDOG 8年前

I feel .25 end of day.

KOLBYDOG

KOLBYDOG 8年前

ATT Have my fingers crossed, believe this to be a big one.

MasterBidder

MasterBidder 8年前

Womp womp booooo

KOLBYDOG

KOLBYDOG 8年前

KOLBYDOG

KOLBYDOG 8年前

NEWS

VANCOUVER, British Columbia, February 27, 2018 /PRNewswire/ --

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (ATT.CN) (ATTBF) is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") to acquire (the "Acquisition") a 90% ownership interest in Gabriola Green Farms Inc. ("Gabriola").

Gabriola is a privately held British Columbia company that has applied for a license to produce (an "LP") under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") on Gabriola Island, one of the gulf islands located in the Strait of Georgia off the coast of British Columbia. Gabriola Island has a consistent temperature and humidity level, which makes it well suited to greenhouse growing.

"This is one of the most significant steps our Company has taken towards becoming a full service cannabis company," stated Rob Abenante, Abattis President and CEO. "After successfully obtaining a license through Gabriola, we intend to not only cultivate marijuana, but more importantly sell extracted cannabis products, which will complete our full downstream service offerings."

The Definitive Agreement comes following a series of rapid acquisitions, capital raises, investments and joint-ventures for the Company, which include the acquisition of a cash flowing vaporizer company, investment into a cutting-edge Blockchain technology and cryptocurrency and several collaborations with respected organizations, including the University of British Columbia.

Rhodeo

everyone uses the american version of this board ATTBF

Already made it

Already made it 8年前

The demand these extractions far exceeds the current supply. And will always be for the next 5-10 yrs IMO

All MJ companies will profit.. as Donald trump says “Huuuuuige”

snidclothing

snidclothing 8年前

Where is everyone? How does att add up amongst the "extractors"?

Anty_Jr

Anty_Jr 8年前

News - Abattis Announces Expansion of Northern Vine Dealer’s License
https://finance.yahoo.com/news/abattis-announces-expansion-northern-vine-120000894.html

Abattis Bioceuticals

Xtrackers IE Public

Health Advance (ID)

WAM Strategic Value

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。